On the other hand, GSTO1 knockout (Fig. 3J) and treatment with a GSTO1 inhibitor (Fig. 3K) sensitized bladder cancer cells to cisplatin cytotoxicity. The gene discussed is GSTO1; the disease is urinary bladder cancer.